Neurocrine Biosciences (NBIX) Misses Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.40 -0.39%
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction
- B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
